Previously known as RaNA Therapeutics. Translate Bio is a leading biotechnology company focused on pioneering the translation of RNA science into therapeutics promoting healthy gene expression in people living with debilitating genetic diseases. The company’s RNA platforms for powering endogenous therapeutic protein production is applicable to a broad range of diseases including rare diseases of the liver, lung and central nervous system (CNS). For more information about the company, please visit www.translate.bio.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $20.7M
Founded date: 2011
Investors 4
| Date | Name | Website |
| 05.03.2022 | M Ventures | m-ventures... |
| - | Omega Fund... | omegafunds... |
| - | MRL Ventur... | mrlv.com |
| - | Atlas Vent... | atlasventu... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.01.2012 | - | $20.7M | - |
Mentions in press and media 16
| Date | Title | Description |
| 07.10.2024 | Kailera Therapeutics: $400 Million (Series A) Raised To Advance Next-Gen Therapies For Obesity | Kailera Therapeutics announced its launch as a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for treating obesity and related conditions. And Kailera launches with a $400 million... |
| 06.08.2021 | Translate Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update | -- Entered into a definitive agreement under which Sanofi will acquire, subject to customary conditions to closing, all outstanding shares of Translate Bio with a goal of advancing deployment of mRNA technology across vaccines and therapeut... |
| 04.08.2021 | Why the IPO markets aren’t quite the dotcom bubble all over again | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. The now common phrase, that the pandemic has “accelerated digital trends,” has more recently been... |
| 04.08.2021 | Why the IPO markets aren’t quite the dotcom bubble all over again | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content Change your marketer experience and unleash growth for your business From Optimizely... |
| 19.04.2021 | TRANSLATE BIO, INC. Translate Bio Announces Key Leadership Additions and Promotions | -- Seasoned healthcare executive, Brendan Smith, appointed as Chief Financial Officer, bringing strategic operations and financial leadership -- -- Appointments enhance capabilities across pulmonary programs, manufacturing and financial ope... |
| 19.04.2021 | TRANSLATE BIO, INC. Translate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj Vaccines | -- Multiple antigen constructs, including the construct used in MRT5500, induced potent neutralizing antibodies against SARS-CoV-2 in preclinical studies in multiple species -- -- Efficacy demonstrated in Syrian Golden Hamster challenge mod... |
| 12.03.2021 | Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate | Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate Clinical trial to assess safety, immune response and reactogenicity, after preclinical data showed high neutralizing antibody levels Expected to e... |
| 18.02.2021 | Translate Bio to Present at the SVB Leerink Virtual 10th Annual Global Healthcare Conference | LEXINGTON, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or ... |
| 16.04.2020 | Covid-19 vaccine tracker updated to include GSK/Sanofi collaboration | By Jeff Craven Currently, there are no FDA-approved therapies or vaccines for SARS-CoV-2, the virus that causes Covid-19. The National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes... |
| 09.04.2020 | Covid-19 Tracker updates vaccine candidates | By Jeff Craven On March 11, the World Health Organization classified the Covid-19 outbreak as a pandemic. The disease has reached nearly every country, infecting hundreds of thousands of people and killing thousands. Curr... |
Show more